Related Experiment Video

Updated: Jul 16, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose

Ilker Tasci1, Teoman Dogru, Alper Sonmez

  • 1Department of Internal Medicine, Gulhane School of Medicine, Ankara, Turkey.

Mediators of Inflammation
|March 30, 2007
PubMed

Insights

Individuals with impaired fasting glucose (IFG) show no increase in soluble CD40L (sCD40L) or high-sensitivity C-reactive protein (hsCRP). This suggests sCD40L may not be an independent risk factor for atherosclerosis in IFG.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Immunology

Background:

  • Impaired fasting glucose (IFG) risk for atherosclerosis remains unclear, unlike diabetes mellitus and impaired glucose tolerance.
  • The CD40-CD40 ligand pathway is implicated in atherosclerotic mechanisms.

Purpose of the Study:

  • To investigate elevated levels of soluble CD40L (sCD40L) and high-sensitivity C-reactive protein (hsCRP) in IFG subjects.
  • To assess IFG's association with inflammation and atherosclerosis markers, excluding confounding factors.

Main Methods:

  • Studied 24 IFG subjects without other disorders and 40 healthy controls.
  • Measured serum levels of sCD40L and hsCRP.
  • Analyzed blood pressure, lipid profiles, and HOMA-IR index.

Main Results:

  • sCD40L and hsCRP levels were similar between IFG and control groups.
  • IFG group showed lower HDL-cholesterol and higher HOMA-IR index.
  • Blood pressure and other lipid parameters were comparable.

Conclusions:

  • sCD40L levels do not appear altered in IFG subjects.
  • sCD40L may not be an independent risk factor for atherosclerosis in IFG.
  • Further research with larger cohorts is warranted.

More Related Videos

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood06:28

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood

Published on: August 12, 2016

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...